Evaluation of Safety, Tolerability and Immune Responses of Ebola-S and Marburg Vaccines in Healthy Adults
Conditions: Ebola Virus Disease; Marburg Virus Disease Interventions: Biological: cAd3-Marburg; Biological: cAd3-EBO-S Sponsors: Albert B. Sabin Vaccine Institute; ICON plc; Oklahoma Blood Institute Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials